Enoxaparin In The Cardiac Patient

2/27/2003


Click here to start


Table of Contents

PPT Slide

aPTT in Patients Receiving UFH

ESSENCE Study Design

ESSENCE Results

CONCLUSIONS

TIMI 11B Study Design

TIMI 11B Results: Early Treatment Phase

TIMI 11B Results: Primary Endpoint

TIMI 11B-ESSENCE Meta-Analysis

TIMI 11B-ESSENCE Meta-Analysis Results: Death/MI

TIMI 11B-ESSENCE Meta-Analysis One-Year Follow-up

TIMI 11B-ESSENCE Meta-Analyses Conclusions

Clinical Event Rates in UA/NSTEMI Trials

PURSUIT Results

INTERACT Results

INTERACT Results

Pharmacokinetics of Enoxaparin

ACC/AHA 2002 Guidelines Management of UA/NSTEMI

What are the new labeling changes?

NEW WARNING:

NEW PRECAUTIONS:

NEW PRECAUTIONS:

Mechanical Valve Thrombosis with Enoxaparin

South African Study

ACCP Recommendations Pregnant Patients with Mechanical Valves

Peri-Procedure Bridging with Enoxaparin

Peri-Procedure Bridging with Enoxaparin

Peri-Procedure Bridging with Enoxaparin

Peri-Procedure Bridging with Enoxaparin

PPT Slide

“Bridge” Therapy: Cost Effectiveness

Summary: Enoxaparin Bridging

ACCP-Management of Oral Anticoagulation During Invasive Procedures

www.CareInternet.com

Author: Thomas M. Hyers, M.D.

Email: slideshows@careinternet.net

Home Page: http://www.careinternet.com